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Recent studies have suggested that Helicobacter pylori (H. pylori) infection might be a risk factor for atherosclerosis. 
Since the bacterium has not been isolated from atherosclerotic lesions, a direct role in atherogenesis is not plau-
sible. We examined associations of plasma total homocysteine (tHcy) and serum folate, independent risk factors 
for atherosclerosis, with H. pylori infection and subsequent gastric atrophy among 174 patients (78 males and 96 
females) aged 20 to 73 years, who visited an H. pylori eradication clinic of Nagoya University from July 2004 to 
October 2005. Polymorphism genotyping was conducted for methylenetetrahydrofolate reductase (MTHFR) C677T 
and thymidylate synthase (TS) 28-bp tandem repeats by PCR with confronting two-pair primers and PCR, respec-
tively. H. pylori infection and gastric atrophy were not significantly associated with hyperhomocysteinemia (tHcy 
≥ 12 nmol/ml), when adjusted by sex, age, smoking, alcohol, and genotypes of MTHFR and TS. The adjusted 
odds ratio of gastric atrophy for low folate level (≤ 4mg/ml) was 0.21 (95% confidence interval = 0.05-0.78). The 
associations of tHcy with serum folate and MTHFR genotype were clearly observed in this dataset. The present 
study demonstrated that folate and MTHFR genotype were the deterministic factors of plasma tHcy, but not H. 
pylori infection and subsequent gastric atrophy, indicating that even if H. pylori infection influences the risk of 
atherosclerosis, the influence may not be through the elevation of homocysteine. 
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1.  Introduction 
Several epidemiologic studies have shown asso-
ciations between persistent gastric infection with 
Helicobacter pylori and ischemic disorders [1-4]. The 
ischemic diseases are also associated with plasma total 
homocysteine (tHcy) level [5-7]. Hyperhomocysteine-
mia, usually defined as a plasma homocysteine level 
greater than 15 nmol/ml, has been found in 5% to 10% 
of general populations [8, 9], and as high as 30% of the 
population aged 65 and older in the Framingham 
Heart Study (tHcy > 14 nmol/ml) [10]. Increasing tHcy 
concentrations accelerate cardiovascular diseases by 
promoting vascular inflammation, endothelial dys-
function, and hypercoagulability [11]. 
An important metabolic pathway for homocys-
teine is the remethylation cycle; in this reaction ho-
mocysteine is converted into methionine by methion-
ine synthase. The folic acid–methionine pathway is 
particularly relevant to the control of genome stability, 
and involves a number of critical enzymes for which 
several polymorphisms have been identified. The ac-
tivity of methylenetetrahydrofolate reductase 
(MTHFR) can be reduced by polymorphisms of 
MTHFR that alter its affinity for the substrate or co-
factor [12]. There were several studies on the associa-
tion between hyperhomocysteinemia and H. pylori 
infection, but the results were inconsistent [1, 2, 13-16]. 
Thymidylate synthase (TS) gene encodes the en-
zyme that catalyzes the conversion of deoxyuridylate 
to thymidylate. The enzyme expression is reportedly 
affected by a 28bp tandem repeat polymorphism. The 
3R3R homozygotes increased tHcy in a Chinese 
population, possibly because TS and MTHFR compete 
for limiting supplies of folate, which is required for the 
remethylation of homocysteine [17]. However, another 
study showed that the tHcy concentrations for 3R3R 
homozygotes did not differ significantly from those for 
2R2R homozygotes or 2R3R heterozygotes in healthy 
young subjects [18].   
Several pathways by which H. pylori infection 
could lead to atherosclerosis have been hypothesized Int. J. Med. Sci. 2007, 4 
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(Figure 1). Among them, the routes from H. pylori in-
fection to gastric atrophy and from low folate concen-
tration to hyperhomocysteinemia are well established. 
But the routes between H. pylori infection and hyper-
homocysteinemia are not confirmed. The aim of our 
study was to examine the hypothesized association 
between  H. pylori infection and hyperhomocysteine-
mia adjusted with MTHFR, TS, sex, and age. The pre-
sent study was approved by the Ethics Committee of 
Nagoya University Graduate School of Medicine (ap-
proval number 174). 
 
Figure 1. Hypothesized pathways from Helicobacter pylori 




Figure 2. Correlation between serum folate and plasma total 
homocysteine according to MTHFR C677T genotype among 
those with serum folate < 8.0 ng/ml 
2.  Patients and Methods 
Study Subjects 
  Subjects were patients who visited Daiko Medi-
cal Center of Nagoya University in Nagoya Japan for 
H. pylori infection tests and subsequent eradication 
treatment, from July 2004 to October 2005. Those aged 
20 to 75 years were enrolled after the informed con-
sent on polymorphism genotyping. Participants who 
had smoked less than 100 cigarettes in their lifetime 
were categorized as never smokers, and all others 
were categorized as ever smokers. Participants who 
had drunk alcoholic beverages at least once a week 
were categorized as “Yes”, and the rest were as “No”. 
When the subjects were positive for serology and/or 
urea breath test, they were classified into positive for 
H. pylori infection. Gastric atrophy was assessed with 
serum pepsinogens (PGI < 70ng/dl and PGI/II < 3). 
Blood samples were collected for measurement of 
plasma tHcy and serum folate. We defined tHcy levels 
of 12 nmol/ml and more as hyperhomocysteinemia, 
and folate levels of 4 mg/dl and lower as lower serum 
folate based on the frequency distribution (the highest 
and lowest quartile, respectively). 
Genotyping 
DNA was extracted from buffy coat conserved at 
–40℃ using a BioRobot® EZ1 (QIAGEN Group, To-
kyo).  MTHFR C677T polymorphism was genotyped 
by a polymerase chain reaction with confronting 
two-pair primers (PCR-CTPP) [19]. Each 25 µl reaction 
tube contained 50-80ng DNA, 0.12 mM dNTP, 12.5 
pmol of each primer, 0.5 U AmpliTaq Gold 
(Perkin-Elmer, Foster City, CA) and 2.5 µl of 10x PCR 
buffer including 15 mM MgCl2. The PCR was con-
ducted with initial denaturation at 95°C for 10 minutes, 
30 cycles of denaturation at 95°C for 1 minute, an-
nealing at 60°C for 1 minute, and extension at 72°C for 
1 minute, and a final extension at 72°C for 5 minutes. 
The primers were F1: 5’-AGC CTC TCC TGA CTG 
TCA TCC-3’, R1: 5’-TGC GTG ATG ATG AAA TCG 
G-3’, F2: 5’-GAG AAG GTG TCT GCG GGA GT-3’, 
and R2: 5’-CAT GTC GGT GCA TGC CTT-3’. The am-
plified DNA fragments were 128-base pairs (bp) for 
the  C allele, 93-bp for the T allele, and 183-bp for 
common band. The tandem repeat sequences in the 
5’-terminal of the regulatory region of the TS gene 
were detected by PCR assay as previously reported 
[20].  
Statistical analysis 
Differences in age, sex, smoking status, alcohol 
consumption, concentration of serum folate and tHcy, 
and genotype frequencies between the positives and 
the negatives of H. pylori infection and gastric atrophy 
were examined by a Mann-Whitney U test  or 
chi-square test. Sex-age-adjusted odds ratio (OR), 95% 
confidence interval (CI), and interaction term of hy-
perhomocysteinemia and lower serum folate were 
estimated with an unconditional logistic model. All 
statistics were calculated by the computer program 
StatView Version 5 (SAS Institute Inc.). 
Hardy-Weinberg equilibrium was also examined. 
3.  Results 
One hundred seventy four patients participated 
in this study. There were 4 patients whose gastric at-Int. J. Med. Sci. 2007, 4 
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rophy was not examined by the pepsinogen test. The 
H. pylori positive perticipants were 115 (66.1%) in all 
patients, and gastric atrophy was observed in 46/170 
(27.1%). The gastric atrophy was in 39.1% among 115 
positive individuals. Gastric atrophy without H. pylori 
infection was found for only one patient who had un-
dergone an H. pylori eradiation treatment. 
The characteristics of patients according to H. py-
lori infection and gastric atrophy are shown in Table 1. 
Age was significantly associated with H. pylori infec-
tion and gastric atrophy. There were no significant 
differences in sex, smoking status and drinking status 
between the groups compared. The frequencies of 
MTHFR and TS genotypes were similar between the 
positives and the negatives. The observed frequencies 
of the two polymorphisms did not deviate from 
Hardy-Weinberg equilibrium (p=0.10 for MTHFR and 
p= 0.59 for TS).
Table 1. Characteristics according to H. pylori infection and gastric atrophy 
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There was a strong association between plasma 
tHcy and the MTHFR genotype. Concentration of 
tHcy was significantly higher for TT genotype (13.9±
9.4 nmol/ml) than for CC/CT genotype (9.7±2.9 
nmol/ml) (p<0.0001). The other factors elevating tHcy 
level were males and ever smokers. The factors re-
ducing serum folate level were males, ever smokers 
and drinkers. As the concentration of folate became 
lower, the difference in elevation of the tHcy concen-
tration due to MTHFR polymorphism became larger. 
The MTHFR genotype had the strongest influence on 
the elevation of tHcy concentration among the factors 
examined. Figure 2 shows the correlation between 
folate and tHcy among those with folate < 8.0ng/ml. 
The slope of the regression line was steepest for those 
with TT genotype (slope = -4.61). Those with folate ≥ 
8.0ng/ml had stable tHcy levels.   
No significant differences in concentrations of 
serum folate and tHcy were found between the posi-
tives and the negatives of H. pylori infection and gas-
tric atrophy according to the genotypes of MTHFR 
and  TS in any subgroups defined by the genotypes 
(Table 2). 
Table 3 shows the ORs and 95% CIs of hyper-
homocysteinemia (≥12 nmol/ml), adjusted for age, 
sex, and the factors listed in the Table. The OR was 
above unity for H. pylori infection and below unity 
for gastric atrophy, through not significant. The OR 
of genotype of MTHFR was not significant in the 
multivariate analysis for hyperhomocysteinemia. 
Table 4 shows the ORs and 95% CIs for folate ≤ 4 
mg/ml, adjusted for the same factors. Gastric atro-
phy decreased a risk of lower serum folate (adjusted 
OR=0.21, 95% CI, 0.05-0.78). Smoking status was a 
significant factor of lower serum folate. 
Table 2. Concentrations of serum folate and plasma total homocysteine according to genotypes of methylenetetrahydrofolate re-
ductase (MTHFR) and thymidylate synthase (TS), H. pylori infection and gastric atrophy 
 
Table 3. Odds ratio (OR) and 95% confidence interval (95% CI) of hyperhomocysteinemia (≥ 12 n mol/ml), adjusted for age, sex, 
and the factors listed 
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Table 4. Odds ratio (OR) and 95% confidence interval (95% CI) of lower serum folate (≤ 4 mg/ml), adjusted for age, sex, and the 
factors listed 
 
4.  Discussion 
Hyperhomocysteinemia is a well-established in-
dependent risk factor for the development of athero-
sclerosis-related diseases due to vascular endothelial 
damage and hypercoagulability. Some studies dem-
onstrated an association between H. pylori infection 
and hyperhomocysteinemia [1-4], while the other 
studies did not. [15, 16, 21-23]. Our study taking into 
the genotypes of folate metabolizing enzymes did not 
indicate the association.   
A number of studies on the possible H. pylori in-
volvement for coronary heart disease have been pub-
lished with conflicting results [24, 25], but a 
meta-analysis reported no strong association between 
H. pylori infection and ischemic heart disease in 1988 
[26]. Recent reports consistently revealed the associa-
tion between Cag A-positive H. pylori and vascular 
risk [27, 28]. On the other hand, there were many re-
ports of positive associations of stroke and carotid ar-
tery disease with H. pylori infection. In addition, there 
was a strong association in subgroup analysis of pa-
tients with different etiologies of cerebral ischemia 
[29-31].  
  Epidemiologic studies have shown that homo-
cysteine is associated with sex, age, smoking status 
and drinking status [8]. In Japan, Moriyama et al re-
ported that age-adjusted plasma homocysteine levels 
were higher for both men and women with the TT 
genotype than those with CC or CT genotype in their 
cross-sectional study [32]. Casas et al searched for all 
relevant studies on the association between homocys-
teine concentration and MTHFR polymorphism, and 
reported that homocysteine concentration between TT 
and CC homozygotes was 1.93 µmol/L and the odds 
ratio for stroke was 1.26 (95% CI, 1.14 to 1.40) for TT 
versus  CC homozygotes [33]. A meta-analysis re-
ported that ischemic stroke risk increased with in-
creasing  MTHFR 677T allele dose, suggesting an in-
fluence of this polymorphism as a genetic stroke risk 
factor [34]. But another recent meta-analysis reported 
that no strong evidence existed to support an associa-
tion heart disease in Europe, North America, or Aus-
tralia [35]. Devlin et al reported that the affection of 
MTHFR polymorphism to hyperhomocysteinemia was 
significantly strong in lower folate level [36]. Our re-
sult supported that the MTHFR C677T polymorphism 
was associated with homocysteine concentration, and 
persons with TT genotype trended to be a hyperho-
mocysteinemia in lower folate level (Figure 2). It is 
important to include this factor for evaluation of the 
association between H. pylori infection and homocys-
teine.  
There are three steps in this logical proposition. 
First step is that H. pylori infection causes to gastric 
atrophy, and second step is that gastric atrophy makes 
malabsorption to reduce serum folate level. And last 
step is that lower folate level causes tHcy level eleva-
tion. 
The first step was well established [37]; our study 
also showed a very strong association between gastric 
atrophy and H. pylori infection. In the second step, 
there were few reports demonstrated that gastric at-
rophy blocked the absorption of folate. Gastric atro-
phy causes an increase in gastric pH and a decrease in 
ascorbic acid; the two mechanisms may cause a reduc-
tion in folate absorption [38, 39]. In the present study, 
gastric atrophy decreased a risk of lower folate oppo-
site to what we expected. There were no other factors 
available for the adjustment, so the reason for this sig-
nificant association was unknown. Anyway, gastric 
atrophy may not increase a risk of lower folate. H. py-
lori infection was not significantly associated with 
lower folate level and hyperhomocysteinemia.   
The last step was demonstrated by several stud-
ies. Markedly elevated homocysteine concentration 
have been observed in patients with nutritional defi-
ciencies of the essential cofactor vitamin B12 and the 
cosubstrate folate [40, 41]. But these are negative re-
ports for subjects with high folate levels [1, 10]. Our Int. J. Med. Sci. 2007, 4 
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present study showed that TT genotype of MTHFR 
trended to have hyperhomocysteinemia in lower 
folate level, and tHcy was low among those with high 
folate level independently on the genotypes. 
Because there is no consistent evidence, the hy-
pothesis that H. pylori causes hyperhomocysteinemia 
was still controversial. Recent studies reported that no 
significant difference in blood homocysteine level 
between the positives and the negatives [14-16]. Our 
logistic analysis showed the similar results indicating 
that there is no link from H. pylori infection to hyper-
homocysteinemia. 
5.  Conclusion 
This study was the first study that analyzed as-
sociation between H. pylori infection and hyperhomo-
cysteinemia in normal subjects taking into account the 
polymorphism of MTHFR. There was no significant 
difference in concentration of serum folate and tHcy 
between those with and without H. pylori infection 
and gastric atrophy. We found a trend to elevate tHcy 
in TT genotype of MTHFR as lower serum folate. Our 
result suggested that there are no pathways from H. 
pylori infection to hyperhomocysteinemia in Japanese 
and an alternative pathway may exist in association of 
H. pylori infection to atherosclerosis, if exists. 
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